8 analysts have expressed a variety of opinions on Surgery Partners (NASDAQ:SGRY) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $42.25, a high estimate of $50.00, and a low estimate of $31.00. Observing a downward trend, the current average is 4.28% lower than the prior average price target of $44.14. Inte…